P-tau235: a novel biomarker for staging preclinical Alzheimer's disease.

EMBO Mol Med · 2021 · PMC8649868 · PMID 34725927

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

No significant differences could be found between Braak III/IV and V/VI ( P = 1.0), although CSF p‐tau235 appeared to display an increasing trend (Appendix Fig S4 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.